
To zzso the effects of zzso therapy zzso on components of the zzso syndrome in zzso zzso 

Comprehensive searches of electronic databases were performed from April 1966 to October zzso We included zzso controlled trials that were of at least 8 weeks duration and evaluated the effect of zzso on zzso inflammatory or zzso zzso zzso resistance was calculated by zzso model assessment zzso zzso analysis evaluated the effects for zzso and oral treatment and for diabetic and zzso zzso 

zzso results of 107 trials showed that zzso reduced abdominal fat zzso zzso zzso to zzso zzso zzso zzso zzso to zzso and zzso diabetes zzso risk zzso zzso zzso in women without zzso In women with diabetes, zzso reduced zzso zzso zzso zzso zzso to zzso and zzso zzso zzso zzso to zzso zzso also reduced zzso zzso zzso cholesterol ratio zzso zzso zzso to zzso zzso zzso zzso zzso zzso to zzso mean blood pressure zzso zzso zzso to zzso zzso zzso zzso zzso to zzso zzso zzso zzso zzso to zzso and zzso zzso zzso zzso zzso zzso to zzso zzso agents produced larger beneficial effects than zzso agents, but increased zzso protein zzso zzso zzso zzso and decreased protein S zzso zzso zzso to zzso while zzso agents had no zzso 

zzso reduces abdominal zzso insulin resistance, zzso diabetes, zzso blood pressure, zzso molecules and zzso factors in women without diabetes and reduced insulin resistance and zzso zzso in women with zzso zzso agents adversely affected zzso and protein zzso while zzso agents had no zzso 

